Joseph M. Burnett - 10 Oct 2025 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
CEO and President, Director
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett
Issuer symbol
CLPT
Transactions as of
10 Oct 2025
Net transactions value
-$714,021
Form type
4
Filing time
14 Oct 2025, 16:33:00 UTC
Previous filing
02 Jul 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BURNETT JOSEPH CEO and President, Director C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH /s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett 14 Oct 2025 0001721010

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLPT Common Stock Sale $466,125 -17,583 -7.2% $26.51 225,939 10 Oct 2025 See Footnote F1, F2, F3
transaction CLPT Common Stock Sale $182,396 -6,599 -2.9% $27.64 219,340 10 Oct 2025 See Footnote F1, F3, F4
transaction CLPT Common Stock Sale $56,736 -1,981 -0.9% $28.64 217,359 10 Oct 2025 See Footnote F1, F3, F5
transaction CLPT Common Stock Sale $8,763 -300 -0.14% $29.21 217,059 10 Oct 2025 See Footnote F1, F3
holding CLPT Common Stock 11,311 10 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.
F2 Represents a weighted average sales price per share. The shares were sold at prices ranging from $26.07 to $27.06. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
F4 Represents a weighted average sales price per share. The shares were sold at prices ranging from $27.08 to $28.07. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 Represents a weighted average sales price per share. The shares were sold at prices ranging from $28.08 to $29.05. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.